# Effects of GABA Modulator AZD7325 on Cutaneous Sensation

> **NCT02530580** · PHASE1 · COMPLETED · sponsor: **University College, London** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 20 mg AZD7325
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02530580
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02530580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02530580, "Effects of GABA Modulator AZD7325 on Cutaneous Sensation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02530580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*